{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:35:51Z","timestamp":1783971351612,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,11,17]],"date-time":"2012-11-17T00:00:00Z","timestamp":1353110400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00277-012-1631-y","type":"journal-article","created":{"date-parts":[[2012,11,16]],"date-time":"2012-11-16T16:43:16Z","timestamp":1353084196000},"page":"533-541","source":"Crossref","is-referenced-by-count":61,"title":["Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum \u03b2-lactamase production and its impact on outcome"],"prefix":"10.1007","volume":"92","author":[{"given":"Si-Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Cheol","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Mi","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Gun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Hee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Hyun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hong","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Sik","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Seong","family":"Eom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Je","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Ki","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Goo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Wook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-Sung","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,17]]},"reference":[{"issue":"Suppl 1","key":"1631_CR1","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.ijantimicag.2007.06.012","volume":"30","author":"J Klastersky","year":"2007","unstructured":"Klastersky J, Ameye L, Maertens J, Georgala A, Muanza F, Aoun M, Ferrant A, Rapoport B, Rolston K, Paesmans M (2007) Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents 30(Suppl 1):S51\u2013S59","journal-title":"Int J Antimicrob Agents"},{"key":"1631_CR2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s150100070007","volume":"28","author":"TA Madani","year":"2000","unstructured":"Madani TA (2000) Clinical infections and bloodstream isolates associated with fever in patients undergoing chemotherapy for acute myeloid leukemia. Infection 28:367\u2013373","journal-title":"Infection"},{"key":"1631_CR3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1469-0691.2005.01298.x","volume":"12","author":"M Norgaard","year":"2006","unstructured":"Norgaard M, Larsson H, Pedersen G, Schonheyder HC, Sorensen HT (2006) Risk of bacteraemia and mortality in patients with haematological malignancies. Clin Microbiol Infect 12:217\u2013223","journal-title":"Clin Microbiol Infect"},{"key":"1631_CR4","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1086\/322604","volume":"33","author":"BA Collin","year":"2001","unstructured":"Collin BA, Leather HL, Wingard JR, Ramphal R (2001) Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 33:947\u2013953","journal-title":"Clin Infect Dis"},{"key":"1631_CR5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3346\/jkms.2006.21.2.199","volume":"21","author":"SH Park","year":"2006","unstructured":"Park SH, Choi SM, Lee DG, Choi JH, Yoo JH, Lee JW, Min WS, Shin WS, Kim CC (2006) Current trends of infectious complications following hematopoietic stem cell transplantation in a single center. J Korean Med Sci 21:199\u2013207","journal-title":"J Korean Med Sci"},{"key":"1631_CR6","doi-asserted-by":"crossref","unstructured":"Kim SH, Kee SY, Lee DG, Choi SM, Park SH, Kwon JC, Eom KS, Kim YJ, Kim HJ, Lee S, Min CK, Kim DW, Choi JH, Yoo JH, Lee JW, Min WS (2012) Infectious complications following allogeneic stem cell transplantation: reduced-intensity vs. myeloablative conditioning regimens. Transpl Infect Dis. doi: 10.1111\/tid.12003","DOI":"10.1111\/tid.12003"},{"key":"1631_CR7","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR, Infectious Diseases Society of America (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52:e56\u2013e93","journal-title":"Clin Infect Dis"},{"key":"1631_CR8","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1128\/AAC.01509-06","volume":"51","author":"M Tumbarello","year":"2007","unstructured":"Tumbarello M, Sanguinetti M, Montuori E, Trecarichi EM, Posteraro B, Fiori B, Citton R, D'Inzeo T, Fadda G, Cauda R, Spanu T (2007) Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-\u03b2-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother 51:1987\u20131994","journal-title":"Antimicrob Agents Chemother"},{"key":"1631_CR9","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/jac\/dks065","volume":"67","author":"WC Rottier","year":"2012","unstructured":"Rottier WC, Ammerlaan HS, Bonten MJ (2012) Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis. J Antimicrob Chemother 67:1311\u20131320","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"1631_CR10","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1007\/s00277-003-0771-5","volume":"82","author":"H Bertz","year":"2003","unstructured":"Bertz H, Auner HW, Weissinger F, Salwender HJ, Einsele H, Egerer G, Sandherr M, Schuttrumpf S, Sudhoff T, Maschmeyer G (2003) Antimicrobial therapy of febrile complications after high-dose chemo-\/radiotherapy and autologous hematopoietic stem cell transplantation. Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82(Suppl 2):S167\u2013174","journal-title":"Ann Hematol"},{"key":"1631_CR11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3904\/kjim.2002.17.1.38","volume":"17","author":"DG Lee","year":"2002","unstructured":"Lee DG, Choi SM, Choi JH, Yoo JH, Park YH, Kim YJ, Lee S, Min CK, Kim HJ, Kim DW, Lee JW, Min WS, Shin WS, Kim CC (2002) Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial. Korean J Intern Med 17:38\u201344","journal-title":"Korean J Intern Med"},{"key":"1631_CR12","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","volume":"34","author":"WT Hughes","year":"2002","unstructured":"Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, Feld R, Pizzo PA, Rolston KV, Shenep JL, Young LS (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34:730\u2013751","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"1631_CR13","first-page":"79","volume":"7","author":"C Carbon","year":"1995","unstructured":"Carbon C (1995) Overview of the efficacy of isepamicin in the adult core clinical trial programme. J Chemother 7(Suppl 2):79\u201385","journal-title":"J Chemother"},{"key":"1631_CR14","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1128\/AAC.06358-11","volume":"56","author":"S Maraki","year":"2012","unstructured":"Maraki S, Samonis G, Karageorgopoulos DE, Mavros MN, Kofteridis D, Falagas ME (2012) In vitro antimicrobial susceptibility to isepamicin of 6,296 Enterobacteriaceae clinical isolates collected at a tertiary care university hospital in Greece. Antimicrob Agents Chemother 56:3067\u20133073","journal-title":"Antimicrob Agents Chemother"},{"key":"1631_CR15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3904\/kjim.2011.26.2.220","volume":"26","author":"DG Lee","year":"2011","unstructured":"Lee DG, Kim SH, Kim SY, Kim CJ, Park WB, Song YG, Choi JH (2011) Evidence-based guidelines for empirical therapy of neutropenic fever in Korea. Korean J Intern Med 26:220\u2013252","journal-title":"Korean J Intern Med"},{"key":"1631_CR16","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.5858\/2005-129-1222-TIBCCA","volume":"129","author":"LG Bekeris","year":"2005","unstructured":"Bekeris LG, Tworek JA, Walsh MK, Valenstein PN (2005) Trends in blood culture contamination: a College of American Pathologists Q-Tracks study of 356 institutions. Arch Pathol Lab Med 129:1222\u20131225","journal-title":"Arch Pathol Lab Med"},{"key":"1631_CR17","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B Pauw De","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Munoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis 46:1813\u20131821","journal-title":"Clin Infect Dis"},{"key":"1631_CR18","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","volume":"101","author":"RC Bone","year":"1992","unstructured":"Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine. Chest 101:1644\u20131655","journal-title":"Chest"},{"key":"1631_CR19","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","volume":"270","author":"JR Gall Le","year":"1993","unstructured":"Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European\/North American multicenter study. JAMA 270:2957\u20132963","journal-title":"JAMA"},{"key":"1631_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49:1\u201345","journal-title":"Clin Infect Dis"},{"key":"1631_CR21","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/508877","volume":"43","author":"J Rodriguez-Bano","year":"2006","unstructured":"Rodriguez-Bano J, Navarro MD, Romero L, Muniain MA, de Cueto M, Rios MJ, Hernandez JR, Pascual A (2006) Bacteremia due to extended-spectrum \u03b2 -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin Infect Dis 43:1407\u20131414","journal-title":"Clin Infect Dis"},{"key":"1631_CR22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0167-9473(01)00048-2","volume":"39","author":"SB Bull","year":"2002","unstructured":"Bull SB, Mak C, Greenwood CM (2002) A modified score function estimator for multinomial logistic regression in small samples. Comput Stat Data Anal 39:57","journal-title":"Comput Stat Data Anal"},{"key":"1631_CR23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jac\/dkp411","volume":"65","author":"C Gudiol","year":"2010","unstructured":"Gudiol C, Calatayud L, Garcia-Vidal C, Lora-Tamayo J, Cisnal M, Duarte R, Arnan M, Marin M, Carratala J, Gudiol F (2010) Bacteraemia due to extended-spectrum \u03b2-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome. J Antimicrob Chemother 65:333\u2013341","journal-title":"J Antimicrob Chemother"},{"key":"1631_CR24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00277-011-1247-7","volume":"91","author":"CI Kang","year":"2012","unstructured":"Kang CI, Chung DR, Ko KS, Peck KR, Song JH (2012) Risk factors for infection and treatment outcome of extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy. Ann Hematol 91:115\u2013121","journal-title":"Ann Hematol"},{"key":"1631_CR25","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1086\/516798","volume":"28","author":"EP Hyle","year":"2007","unstructured":"Hyle EP, Bilker WB, Gasink LB, Lautenbach E (2007) Impact of different methods for describing the extent of prior antibiotic exposure on the association between antibiotic use and antibiotic-resistant infection. Infect Control Hosp Epidemiol 28:647\u2013654","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1631_CR26","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1086\/429239","volume":"40","author":"EP Hyle","year":"2005","unstructured":"Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Fishman NO, Bilker WB, Mao X, Lautenbach E (2005) Risk factors for increasing multidrug resistance among extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella species. Clin Infect Dis 40:1317\u20131324","journal-title":"Clin Infect Dis"},{"key":"1631_CR27","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1128\/AAC.01131-09","volume":"54","author":"KM Wener","year":"2010","unstructured":"Wener KM, Schechner V, Gold HS, Wright SB, Carmeli Y (2010) Treatment with fluoroquinolones or with \u03b2-lactam-\u03b2-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-\u03b2-lactamase-producing Klebsiella species in hospitalized patients. Antimicrob Agents Chemother 54:2010\u20132016","journal-title":"Antimicrob Agents Chemother"},{"key":"1631_CR28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1469-0691.2007.01884.x","volume":"14","author":"J Rodriguez-Bano","year":"2008","unstructured":"Rodriguez-Bano J, Navarro MD, Romero L, Muniain MA, Cueto M, Galvez J, Perea EJ, Pascual A (2008) Risk-factors for emerging bloodstream infections caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli. Clin Microbiol Infect 14:180\u2013183","journal-title":"Clin Microbiol Infect"},{"key":"1631_CR29","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1016\/j.ijid.2010.12.010","volume":"15","author":"Y Chong","year":"2011","unstructured":"Chong Y, Yakushiji H, Ito Y, Kamimura T (2011) Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies. Int J Infect Dis 15:e277\u2013e281","journal-title":"Int J Infect Dis"},{"key":"1631_CR30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jinf.2009.02.002","volume":"58","author":"EM Trecarichi","year":"2009","unstructured":"Trecarichi EM, Tumbarello M, Spanu T, Caira M, Fianchi L, Chiusolo P, Fadda G, Leone G, Cauda R, Pagano L (2009) Incidence and clinical impact of extended-spectrum-\u03b2-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. J Infect 58:299\u2013307","journal-title":"J Infect"},{"key":"1631_CR31","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2165\/11533040-000000000-00000","volume":"70","author":"JD Pitout","year":"2010","unstructured":"Pitout JD (2010) Infections with extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 70:313\u2013333","journal-title":"Drugs"},{"issue":"Suppl 1","key":"1631_CR32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1469-0691.2007.01864.x","volume":"14","author":"LR Peterson","year":"2008","unstructured":"Peterson LR (2008) Antibiotic policy and prescribing strategies for therapy of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: the role of piperacillin\u2013tazobactam. Clin Microbiol Infect 14(Suppl 1):181\u2013184","journal-title":"Clin Microbiol Infect"},{"key":"1631_CR33","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jinf.2012.01.008","volume":"64","author":"CI Kang","year":"2012","unstructured":"Kang CI, Park SY, Chung DR, Peck KR, Song JH (2012) Piperacillin\u2013tazobactam as an initial empirical therapy of bacteremia caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae. J Infect 64:533\u2013534","journal-title":"J Infect"},{"key":"1631_CR34","doi-asserted-by":"crossref","unstructured":"Vardakas KZ, Tansarli GS, Rafailidis PI, Falagas ME (2012) Carbapenems vs alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum \u03b2-lactamases: a systematic review and meta-analysis. J Antimicrob Chemother 67:2793\u20132803","DOI":"10.1093\/jac\/dks301"},{"key":"1631_CR35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/cid\/cir790","volume":"54","author":"J Rodriguez-Bano","year":"2012","unstructured":"Rodriguez-Bano J, Navarro MD, Retamar P, Picon E, Pascual A (2012) \u03b2-Lactam\/\u03b2-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum \u03b2-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts. Clin Infect Dis 54:167\u2013174","journal-title":"Clin Infect Dis"},{"key":"1631_CR36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1586\/eri.11.170","volume":"10","author":"ME Falagas","year":"2012","unstructured":"Falagas ME, Karageorgopoulos DE, Georgantzi GG, Sun C, Wang R, Rafailidis PI (2012) Susceptibility of Gram-negative bacteria to isepamicin: a systematic review. Expert Rev Anti Infect Ther 10:207\u2013218","journal-title":"Expert Rev Anti Infect Ther"},{"key":"1631_CR37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/jac\/dkq408","volume":"66","author":"DM Livermore","year":"2011","unstructured":"Livermore DM, Mushtaq S, Warner M, Zhang JC, Maharjan S, Doumith M, Woodford N (2011) Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates. J Antimicrob Chemother 66:48\u201353","journal-title":"J Antimicrob Chemother"},{"key":"1631_CR38","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1128\/AAC.00115-10","volume":"54","author":"JA Martinez","year":"2010","unstructured":"Martinez JA, Cobos-Trigueros N, Soriano A, Almela M, Ortega M, Marco F, Pitart C, Sterzik H, Lopez J, Mensa J (2010) Influence of empiric therapy with a beta-lactam alone or combined with an aminoglycoside on prognosis of bacteremia due to gram-negative microorganisms. Antimicrob Agents Chemother 54:3590\u20133596","journal-title":"Antimicrob Agents Chemother"},{"key":"1631_CR39","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/jac\/dkm318","volume":"60","author":"MJ Schwaber","year":"2007","unstructured":"Schwaber MJ, Carmeli Y (2007) Mortality and delay in effective therapy associated with extended-spectrum \u03b2-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 60:913\u2013920","journal-title":"J Antimicrob Chemother"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1631-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-012-1631-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1631-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T13:30:01Z","timestamp":1643635801000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-012-1631-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,17]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["1631"],"URL":"https:\/\/doi.org\/10.1007\/s00277-012-1631-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,17]]}}}